GGrantIndex
← Leaderboards

Candelaria Gomez-Manzano

University Of Tx Md Anderson Can Ctr

$2,523,797
Attributed
$4,466,433
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $882.9K · FY201025
$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,466,433 · 5

By mechanism

R01$3,655,964 · 2
P50$409,917 · 1
R21$229,309 · 1
U54$171,243 · 1

Top collaborators

Most similar at University Of Tx Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Tumor

Research focus

TumorCellsBrain NeoplasmsMediatingPre-ClinicalClinical TrialsGliomaMalignant NeoplasmsImmunocompetentRecurrenceOperative Surgical ProceduresClinical DataGlioblastomaLaboratoriesMalignant GliomaCancer TherapyCharacteristicsMouse ModelInjectionsOncolytic AdenovirusInfectionCombined Modality TherapyImmunePathway Interactions

Grant awards (18)

Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants$370,575
R01 · FY2025 · CA
Examining the Role of Nono Pathway on the Innate Immunity Against Oncolytic Adenoviruses$229,309
R21 · FY2025 · CA · contact PI
Animal Core (Core D)$201,174
P50 · FY2025 · CA · contact PI
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants$81,881
R01 · FY2025 · CA
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants$352,047
R01 · FY2024 · CA
Animal Core (Core D)$208,743
P50 · FY2024 · CA · contact PI
NCI Diversity Supplement: Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants$69,324
R01 · FY2024 · CA
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants$363,164
R01 · FY2023 · CA
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants$363,164
R01 · FY2022 · CA
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants$370,575
R01 · FY2021 · CA
Pilot Project 1: Combination of Viroimmunotherapy and Microbiota Modulation to Treat Gastric Cancer$64,219
U54 · FY2021 · CA · contact PI
Pilot Project 1: Combination of Viroimmunotherapy and Microbiota Modulation to Treat Gastric Cancer$69,122
U54 · FY2020 · CA · contact PI
Pilot Project 1: Combination of Viroimmunotherapy and Microbiota Modulation to Treat Gastric Cancer$37,902
U54 · FY2019 · CA · contact PI
Role of TEMs in brain tumor dispersal$335,325
R01 · FY2014 · NS · contact PI
Role of TEMs in brain tumor dispersal$326,858
R01 · FY2013 · NS · contact PI
Role of TEMs in brain tumor dispersal$338,713
R01 · FY2012 · NS · contact PI
Role of TEMs in brain tumor dispersal$338,713
R01 · FY2011 · NS · contact PI
Role of TEMs in brain tumor dispersal$345,625
R01 · FY2010 · NS · contact PI